Suppr超能文献

广谱抗病毒药物QL47的构效关系研究

Structure-Activity Relationship Study of QL47: A Broad-Spectrum Antiviral Agent.

作者信息

Liang Yanke, de Wispelaere Melissanne, Carocci Margot, Liu Qingsong, Wang Jinhua, Yang Priscilla L, Gray Nathanael S

机构信息

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States; Departments of Biological Chemistry & Molecular Pharmacology and Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, United States.

Departments of Biological Chemistry & Molecular Pharmacology and Microbiology and Immunobiology, Harvard Medical School , Boston, Massachusetts 02115, United States.

出版信息

ACS Med Chem Lett. 2017 Feb 3;8(3):344-349. doi: 10.1021/acsmedchemlett.7b00008. eCollection 2017 Mar 9.

Abstract

Here we report the structure-activity relationship (SAR) investigations of QL-XII-47 (QL47), a compound that possesses broad-spectrum antiviral activity against dengue virus and other RNA viruses. A medicinal chemistry campaign initiated from QL47, a previously reported covalent BTK inhibitor, to derive YKL-04-085, which is devoid of any kinase activity when screened against a panel of 468 kinases and with improved pharmacokinetic properties. Both QL47 and YKL-04-085 are potent inhibitors of viral translation and exhibit cellular antiviral activity at 35-fold lower concentrations relative to inhibition of host-cell proliferation.

摘要

在此,我们报告了QL-XII-47(QL47)的构效关系(SAR)研究,QL47是一种对登革病毒和其他RNA病毒具有广谱抗病毒活性的化合物。从先前报道的共价BTK抑制剂QL47开始的药物化学研究,衍生出了YKL-04-085,在针对468种激酶进行筛选时,YKL-04-085没有任何激酶活性,并且具有改善的药代动力学性质。QL47和YKL-04-085都是病毒翻译的有效抑制剂,相对于抑制宿主细胞增殖,它们在低35倍的浓度下就表现出细胞抗病毒活性。

相似文献

1
Structure-Activity Relationship Study of QL47: A Broad-Spectrum Antiviral Agent.广谱抗病毒药物QL47的构效关系研究
ACS Med Chem Lett. 2017 Feb 3;8(3):344-349. doi: 10.1021/acsmedchemlett.7b00008. eCollection 2017 Mar 9.
3
Discovery of host-targeted covalent inhibitors of dengue virus.登革病毒宿主靶向共价抑制剂的发现
Antiviral Res. 2017 Mar;139:171-179. doi: 10.1016/j.antiviral.2016.12.017. Epub 2016 Dec 26.

本文引用的文献

1
Discovery of host-targeted covalent inhibitors of dengue virus.登革病毒宿主靶向共价抑制剂的发现
Antiviral Res. 2017 Mar;139:171-179. doi: 10.1016/j.antiviral.2016.12.017. Epub 2016 Dec 26.
3
Development of Selective Covalent Janus Kinase 3 Inhibitors.选择性共价 Janus 激酶 3 抑制剂的研发
J Med Chem. 2015 Aug 27;58(16):6589-606. doi: 10.1021/acs.jmedchem.5b00710. Epub 2015 Aug 18.
8
Ten years of dengue drug discovery: progress and prospects.十年登革热药物研发:进展与展望。
Antiviral Res. 2013 Nov;100(2):500-19. doi: 10.1016/j.antiviral.2013.09.013. Epub 2013 Sep 27.
9
mTOR kinase structure, mechanism and regulation.mTOR 激酶结构、机制与调控。
Nature. 2013 May 9;497(7448):217-23. doi: 10.1038/nature12122. Epub 2013 May 1.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验